Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatic; Functional Disturbance”

170 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 170 results

Not applicableStudy completedNCT01887171
What this trial is testing

Evaluation of Preimplantation Portal Vein and Hepatic Artery Flushing With Tacrolimus

Who this might be right for
Early Allograft DysfunctionIschemic Reperfusion InjuryLiver Transplantation+1 more
Republican Scientific and Practical Center for Organ and Tissue Transplantation 86
Not applicableStudy completedNCT03641872
What this trial is testing

A Validation Cohort for ACLF Diagnosis and Prognosis

Who this might be right for
Liver Failure, Acute on ChronicLiver Dysfunction
Hai Li 1,370
Post-approval studies (Phase 4)Study completedNCT05493761
What this trial is testing

Effect of Anti-osteoporotic Medications on Nonalcoholic Fatty Liver Disease

Who this might be right for
Nonalcoholic Fatty LiverOsteoporosis, Postmenopausal
Aristotle University Of Thessaloniki 72
Large-scale testing (Phase 3)Looking for participantsNCT07165028
What this trial is testing

A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver Disease
Eli Lilly and Company 4,500
Early research (Phase 1)UnknownNCT05195125
What this trial is testing

Use of Direct Peritoneal Resuscitation in High-risk Liver Transplant Recipients

Who this might be right for
End Stage Liver DIseaseObesityAcute Kidney Injury
University of Colorado, Denver 15
Post-approval studies (Phase 4)Active Not RecruitingNCT05031026
What this trial is testing

Dexmedetomidine to Prevent Hepatic Ischemia-reperfusion Injury-induced Glycocalyx Degradation and Early Allograft Dysfunction in Liver Transplantation

Who this might be right for
Liver Transplant; Complications
Assiut University 60
Post-approval studies (Phase 4)Looking for participantsNCT07718126
What this trial is testing

Pre-hepatectomy Rehabilitation in Obese MASLD-Complicated Living Liver Donors With Mazdutide (PRIME)

Who this might be right for
Metabolic Dysfunction-Associated SteatohepatitisHepatic SteatosisLiving Liver Donors
West China Hospital 60
Not applicableLooking for participantsNCT07454824
What this trial is testing

E-ALIGN: A Patient Portal-based Intervention to Align Medications With What Matters Most

Who this might be right for
DementiaPotentially Inappropriate Medication UseMild Cognitive Impairment (MCI)
Johns Hopkins University 100
Not applicableNot Yet RecruitingNCT07337720
What this trial is testing

Liposomal Amphotericin B in Invasive Aspergillosis With Hepatic Dysfunction

Who this might be right for
Aspergillosis Invasive
Southeast University, China 40
Not applicableStudy completedNCT07182136
What this trial is testing

The Impact of Hepatic Steatosis on Survival After Pancreaticoduodenectomy

Who this might be right for
Nonalcoholic Fatty Liver Disease After Pancreaticoduodenectomy
Wei-Hsun Lu 200
Not applicableNot Yet RecruitingNCT06682663
What this trial is testing

Impact of Live Streaming Exercise on Liver Health in MASLD Pregnant Women

Who this might be right for
Metabolic Dysfunction-associated Steatotic Liver Disease
Peking University 220
Early research (Phase 1)Study completedNCT06916078
What this trial is testing

Lepodisiran (LY3819469) in Participants With Normal, Mild, Moderate, or Severe Liver Function

Who this might be right for
Liver DysfunctionHealthy
Eli Lilly and Company 30
Post-approval studies (Phase 4)UnknownNCT02344823
What this trial is testing

Effect of Vardenafil on Erectile Dysfunction and Portal Hemodynamics in Patients With Liver Cirrhosis

Who this might be right for
CirrhosisErectile Dysfunction
Medical University of Vienna 30
Early research (Phase 1)WithdrawnNCT01419548
What this trial is testing

ABT-888, Carboplatin, and Paclitaxel for Cancer With Liver or Kidney Problems

Who this might be right for
Neoplasms
National Cancer Institute (NCI)
Not applicableActive Not RecruitingNCT06662851
What this trial is testing

Usefulness of Ultrasound-derived Fat Fraction for Quantification of Hepatic Steatosis in Patients Suspected of MASLD

Who this might be right for
MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease
So Yeon Kim 150
Not applicableLooking for participantsNCT07552727
What this trial is testing

Rehabilitation With Exercise-Based Intervention for Nonalcoholic Chronic Hepatic Esteatosis

Who this might be right for
Metabolic Adaptation to High-Intensity Interval TrainingMetabolic Associated-dysfunction Steatotic Liver Disease (MASLD)
Universidad San Sebastián 30
Not applicableUnknownNCT02423941
What this trial is testing

Retrograde rEperfusion in Dbd Donor LIver Transplantation

Who this might be right for
Liver TransplantationReperfusionDelayed Graft Function
Republican Scientific and Practical Center for Organ and Tissue Transplantation 90
Large-scale testing (Phase 3)WithdrawnNCT02837939
What this trial is testing

Transfer Factor Efficacy in the Management of Cirrhosis-associated Immune Dysfunction

Who this might be right for
CirrhosisLiver Failure
Martin Janičko
Early research (Phase 1)Study completedNCT00118170
What this trial is testing

Sorafenib in Treating Patients With Metastatic or Unresectable Solid Tumors, Multiple Myeloma, or Non-Hodgkin's Lymphoma With or Without Impaired Liver or Kidney Function

Who this might be right for
Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid TissueNodal Marginal Zone B-cell LymphomaRecurrent Adult Burkitt Lymphoma+42 more
National Cancer Institute (NCI) 150
Early research (Phase 1)Study completedNCT00621725
What this trial is testing

Phase 1 PK Study of Cediranib in Single and Multiple Doses in Hepatically Impaired Patients With Solid Tumours

Who this might be right for
Advanced CancerHepatic Impairment
AstraZeneca 36
Next Page